You're reading the free version. Trader adds the live tape and alerts.
Start tracking
PALI Exercise Disclosure
Finley John David · SEC Form 4 · Filed Jul 8, 2026
Exercise
Calculated transaction value
$93.1
Finley John David CEO, CFO
PALI
Palisade Bio, Inc.
PALI
Transaction date
Jul 7, 2026
Public filing date
Jul 8, 2026
Filing lag
Filed 1 day later
PALI daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 133 shares @ $0.7
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001493152-26-032559
Filing cohort
Transactions in this filing
Showing 5 of 5
Trades
5
Issuers
1
Estimated value
$303.44K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Palisade Bio, Inc. PALI | Sale | Jul 7, 2026 | $303.34K |
| Palisade Bio, Inc. PALI Current | Exercise | Jul 7, 2026 | $93.1 |
| Palisade Bio, Inc. PALI | Exercise | Jul 7, 2026 | $0 |
| Palisade Bio, Inc. PALI | Exercise | Jul 6, 2026 | Not reported |
| Palisade Bio, Inc. PALI | Exercise | Jul 6, 2026 | $0 |